Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12578794.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the incidence and type of posterior segment complications associated with the use of interferon alpha 2b and ribavirin in patients with chronic hepatitis C. A prospective noncomparative case series. Forty-two patients (84 eyes). Patients with chronic hepatitis C were evaluated for ocular changes while being treated with interferon alpha 2b and ribavirin. Patients were followed with sequential ocular examinations for 4 to 20 months. Occurrence of posterior segment complications while on interferon and ribavirin therapy. Twenty-seven patients developed retinopathy. The retinopathy consisted of single-to-multiple cotton-wool spots and retinal hemorrhage and was transient in all cases. An additional patient (age 46) presented with asymptomatic disc edema and hemorrhage. One other individual developed a symptomatic permanent monocular visual field defect. Therapy was discontinued in three patients because of severe posterior segment pathology. Our study demonstrated that a high incidence of retinopathy is associated with the treatment of hepatitis C using interferon and ribavirin, but that this form of retinopathy is relatively benign. Regular ophthalmic monitoring should be performed in patients undergoing this treatment.
Medical subject headings
- Antiviral Agents
- Hepatitis C, Chronic
- Interferon-alpha
- Retina
- Retinal Diseases
- Ribavirin